Examination of pituitary adenylate cyclase-activating polypeptide in Parkinson’s disease focusing on correlations with motor symptoms

The neuroprotective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) have been shown in numerous in vitro and in vivo models of Parkinson’s disease (PD) supporting the theory that PACAP could have an important role in the pathomechanism of the disorder affecting mostly older pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pham, Daniel, Polgar, Beata, Toth, Tunde, Jungling, Adel, Kovacs, Norbert, Balas, Istvan, Pal, Endre, Szabo, Dora, Fulop, Balazs Daniel, Reglodi, Dora, Szanto, Zalan, Herczeg, Robert, Gyenesei, Attila, Tamas, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135934/
https://www.ncbi.nlm.nih.gov/pubmed/35220508
http://dx.doi.org/10.1007/s11357-022-00530-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135934/
https://www.ncbi.nlm.nih.gov/pubmed/35220508
http://dx.doi.org/10.1007/s11357-022-00530-6

Ejemplares similares